These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 18554251)

  • 1. Ligand-induced stabilization and activation of peroxisome proliferator-activated receptor gamma.
    Gani OA; Sylte I
    Chem Biol Drug Des; 2008 Jul; 72(1):50-7. PubMed ID: 18554251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein polarization is critical to stabilizing AF-2 and helix-2' domains in ligand binding to PPAR-gamma.
    Ji CG; Zhang JZ
    J Am Chem Soc; 2008 Dec; 130(50):17129-33. PubMed ID: 19007119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha.
    Gani OA; Sylte I
    J Mol Graph Model; 2008 Sep; 27(2):217-24. PubMed ID: 18547851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma.
    Nolte RT; Wisely GB; Westin S; Cobb JE; Lambert MH; Kurokawa R; Rosenfeld MG; Willson TM; Glass CK; Milburn MV
    Nature; 1998 Sep; 395(6698):137-43. PubMed ID: 9744270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
    J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of docosahexaenoic acid derivatives designed as novel PPARgamma agonists and antidiabetic agents.
    Itoh T; Murota I; Yoshikai K; Yamada S; Yamamoto K
    Bioorg Med Chem; 2006 Jan; 14(1):98-108. PubMed ID: 16198578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: implications for nuclear receptor activation.
    Johnson BA; Wilson EM; Li Y; Moller DE; Smith RG; Zhou G
    J Mol Biol; 2000 Apr; 298(2):187-94. PubMed ID: 10764590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonists.
    Lin CH; Peng YH; Coumar MS; Chittimalla SK; Liao CC; Lyn PC; Huang CC; Lien TW; Lin WH; Hsu JT; Cheng JH; Chen X; Wu JS; Chao YS; Lee HJ; Juo CG; Wu SY; Hsieh HP
    J Med Chem; 2009 Apr; 52(8):2618-22. PubMed ID: 19301897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping.
    Sheu SH; Kaya T; Waxman DJ; Vajda S
    Biochemistry; 2005 Feb; 44(4):1193-209. PubMed ID: 15667213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.
    Zieleniak A; Wójcik M; Woźniak LA
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indenone derivatives: a novel template for peroxisome proliferator-activated receptor gamma (PPARgamma) agonists.
    Ahn JH; Shin MS; Jung SH; Kang SK; Kim KR; Rhee SD; Jung WH; Yang SD; Kim SJ; Woo JR; Lee JH; Cheon HG; Kim SS
    J Med Chem; 2006 Jul; 49(15):4781-4. PubMed ID: 16854085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for peroxisome proliferator-activated receptor-gamma agonists in progression: beyond metabolism.
    Fogo AB
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):282-5. PubMed ID: 18408479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Truxillic acid derivatives act as peroxisome proliferator-activated receptor gamma activators.
    Steri R; Rupp M; Proschak E; Schroeter T; Zettl H; Hansen K; Schwarz O; Müller-Kuhrt L; Müller KR; Schneider G; Schubert-Zsilavecz M
    Bioorg Med Chem Lett; 2010 May; 20(9):2920-3. PubMed ID: 20347594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the improved potency of peroxisome proliferator-activated receptor (PPAR) agonists.
    Peng YH; Coumar MS; Leou JS; Wu JS; Shiao HY; Lin CH; Lin WH; Lien TW; Chen X; Hsu JT; Chao YS; Huang CF; Lyu PC; Hsieh HP; Wu SY
    ChemMedChem; 2010 Oct; 5(10):1707-16. PubMed ID: 20734309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into peroxisome proliferator-activated receptor gamma binding of two ureidofibrate-like enantiomers by molecular dynamics, cofactor interaction analysis, and site-directed mutagenesis.
    Pochetti G; Mitro N; Lavecchia A; Gilardi F; Besker N; Scotti E; Aschi M; Re N; Fracchiolla G; Laghezza A; Tortorella P; Montanari R; Novellino E; Mazza F; Crestani M; Loiodice F
    J Med Chem; 2010 Jun; 53(11):4354-66. PubMed ID: 20462215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studies.
    Mahindroo N; Wang CC; Liao CC; Huang CF; Lu IL; Lien TW; Peng YH; Huang WJ; Lin YT; Hsu MC; Lin CH; Tsai CH; Hsu JT; Chen X; Lyu PC; Chao YS; Wu SY; Hsieh HP
    J Med Chem; 2006 Feb; 49(3):1212-6. PubMed ID: 16451087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of peroxisome proliferator-activated receptor γ activation by luteolin.
    Puhl AC; Bernardes A; Silveira RL; Yuan J; Campos JL; Saidemberg DM; Palma MS; Cvoro A; Ayers SD; Webb P; Reinach PS; Skaf MS; Polikarpov I
    Mol Pharmacol; 2012 Jun; 81(6):788-99. PubMed ID: 22391103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peroxisome proliferator-activated receptor-gamma agonist and other constituents from Chromolaena odorata.
    Dat NT; Lee K; Hong YS; Kim YH; Minh CV; Lee JJ
    Planta Med; 2009 Jun; 75(8):803-7. PubMed ID: 19242902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches.
    Hidalgo-Figueroa S; Ramírez-Espinosa JJ; Estrada-Soto S; Almanza-Pérez JC; Román-Ramos R; Alarcón-Aguilar FJ; Hernández-Rosado JV; Moreno-Díaz H; Díaz-Coutiño D; Navarrete-Vázquez G
    Chem Biol Drug Des; 2013 Apr; 81(4):474-83. PubMed ID: 23289972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.